Monounsaturated fatty acids promote cancer radioresistance by inhibiting ferroptosis through ACSL3

Radioresistance is a major challenge in tumor radiotherapy and involves in a mixture of cellular events, including ferroptosis, a new type of programmed cell death characterized by the excess accumulation of iron-dependent lipid peroxides. In the present study, we observed that surviving cancer tiss...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cell death & disease Jg. 16; H. 1; S. 184 - 13
Hauptverfasser:	Cao, Yulin, Li, Jiuming, Chen, Ying, Wang, Yuanben, Liu, Zhiang, Huang, Liuying, Liu, Bingxin, Feng, Yuyang, Yao, Surui, Zhou, Leyuan, Yin, Yuan, Huang, Zhaohui
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	London Nature Publishing Group UK 18.03.2025 Springer Nature B.V Nature Publishing Group
Schlagworte:	13/51 14/28 631/67/395 64/60 692/699/67/1059/2326 692/699/67/1059/485 692/699/67/1504/1885/1777 82/58 82/80 82/81 Animals Antibodies Antitumor activity Apoptosis Biochemistry Biomedical and Life Sciences Cancer Cell Biology Cell Culture Cell death Cell Line, Tumor Coenzyme A Ligases - genetics Coenzyme A Ligases - metabolism Fatty acids Fatty Acids, Monounsaturated - metabolism Fatty Acids, Monounsaturated - pharmacology Female Ferroptosis Ferroptosis - drug effects Ferroptosis - radiation effects Glutathione Humans Imidazole Immunology Life Sciences Lipids Long-Chain-Fatty-Acid-CoA Ligase Mice Mice, Nude Neoplasms - metabolism Neoplasms - pathology Neoplasms - radiotherapy Oleic acid Oleic Acid - pharmacology Palmitoleic acid Phospholipids Piperazines - pharmacology Polyunsaturated fatty acids Radiation therapy Radiation Tolerance - drug effects Radioresistance Reactive oxygen species Reactive Oxygen Species - metabolism Tumors
ISSN:	2041-4889, 2041-4889
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Abstract	Radioresistance is a major challenge in tumor radiotherapy and involves in a mixture of cellular events, including ferroptosis, a new type of programmed cell death characterized by the excess accumulation of iron-dependent lipid peroxides. In the present study, we observed that surviving cancer tissues and cells after radiotherapy had significantly greater glutathione to oxidized glutathione (GSH/GSSG) ratios and lower lipid reactive oxygen species (ROS) and malondialdehyde (MDA) levels than nonirradiated tumors and cells. Untargeted lipidomic analyses revealed that oleic acid (OA) and palmitoleic acid (POA) were the most significantly upregulated unsaturated fatty acids in irradiated surviving cancer cells compared with those in control cancer cells irradiated with IR. Both OA and POA could protect cancer cells from the killing effects of the ferroptosis inducer erastin and RSL3, and OA had a stronger protective effect than POA, resulting in lower lipid ROS production than POA. Mechanistically, OA protected cells from ferroptosis caused by the accumulation of polyunsaturated fatty acid-containing phospholipids in an ACSL3-dependent manner. A mouse model demonstrated that ACSL3 knockdown combined with imidazole ketone erastin synergistically enhanced antitumor effects in radiation-resistant tumors in vivo. Our study reveals previously undiscovered associations between radiation and fatty acid metabolism and ferroptosis, providing a novel treatment strategy for overcoming cancer radioresistance.
AbstractList	Abstract Radioresistance is a major challenge in tumor radiotherapy and involves in a mixture of cellular events, including ferroptosis, a new type of programmed cell death characterized by the excess accumulation of iron-dependent lipid peroxides. In the present study, we observed that surviving cancer tissues and cells after radiotherapy had significantly greater glutathione to oxidized glutathione (GSH/GSSG) ratios and lower lipid reactive oxygen species (ROS) and malondialdehyde (MDA) levels than nonirradiated tumors and cells. Untargeted lipidomic analyses revealed that oleic acid (OA) and palmitoleic acid (POA) were the most significantly upregulated unsaturated fatty acids in irradiated surviving cancer cells compared with those in control cancer cells irradiated with IR. Both OA and POA could protect cancer cells from the killing effects of the ferroptosis inducer erastin and RSL3, and OA had a stronger protective effect than POA, resulting in lower lipid ROS production than POA. Mechanistically, OA protected cells from ferroptosis caused by the accumulation of polyunsaturated fatty acid-containing phospholipids in an ACSL3-dependent manner. A mouse model demonstrated that ACSL3 knockdown combined with imidazole ketone erastin synergistically enhanced antitumor effects in radiation-resistant tumors in vivo. Our study reveals previously undiscovered associations between radiation and fatty acid metabolism and ferroptosis, providing a novel treatment strategy for overcoming cancer radioresistance. Radioresistance is a major challenge in tumor radiotherapy and involves in a mixture of cellular events, including ferroptosis, a new type of programmed cell death characterized by the excess accumulation of iron-dependent lipid peroxides. In the present study, we observed that surviving cancer tissues and cells after radiotherapy had significantly greater glutathione to oxidized glutathione (GSH/GSSG) ratios and lower lipid reactive oxygen species (ROS) and malondialdehyde (MDA) levels than nonirradiated tumors and cells. Untargeted lipidomic analyses revealed that oleic acid (OA) and palmitoleic acid (POA) were the most significantly upregulated unsaturated fatty acids in irradiated surviving cancer cells compared with those in control cancer cells irradiated with IR. Both OA and POA could protect cancer cells from the killing effects of the ferroptosis inducer erastin and RSL3, and OA had a stronger protective effect than POA, resulting in lower lipid ROS production than POA. Mechanistically, OA protected cells from ferroptosis caused by the accumulation of polyunsaturated fatty acid-containing phospholipids in an ACSL3-dependent manner. A mouse model demonstrated that ACSL3 knockdown combined with imidazole ketone erastin synergistically enhanced antitumor effects in radiation-resistant tumors in vivo. Our study reveals previously undiscovered associations between radiation and fatty acid metabolism and ferroptosis, providing a novel treatment strategy for overcoming cancer radioresistance. Radioresistance is a major challenge in tumor radiotherapy and involves in a mixture of cellular events, including ferroptosis, a new type of programmed cell death characterized by the excess accumulation of iron-dependent lipid peroxides. In the present study, we observed that surviving cancer tissues and cells after radiotherapy had significantly greater glutathione to oxidized glutathione (GSH/GSSG) ratios and lower lipid reactive oxygen species (ROS) and malondialdehyde (MDA) levels than nonirradiated tumors and cells. Untargeted lipidomic analyses revealed that oleic acid (OA) and palmitoleic acid (POA) were the most significantly upregulated unsaturated fatty acids in irradiated surviving cancer cells compared with those in control cancer cells irradiated with IR. Both OA and POA could protect cancer cells from the killing effects of the ferroptosis inducer erastin and RSL3, and OA had a stronger protective effect than POA, resulting in lower lipid ROS production than POA. Mechanistically, OA protected cells from ferroptosis caused by the accumulation of polyunsaturated fatty acid-containing phospholipids in an ACSL3-dependent manner. A mouse model demonstrated that ACSL3 knockdown combined with imidazole ketone erastin synergistically enhanced antitumor effects in radiation-resistant tumors in vivo. Our study reveals previously undiscovered associations between radiation and fatty acid metabolism and ferroptosis, providing a novel treatment strategy for overcoming cancer radioresistance.Radioresistance is a major challenge in tumor radiotherapy and involves in a mixture of cellular events, including ferroptosis, a new type of programmed cell death characterized by the excess accumulation of iron-dependent lipid peroxides. In the present study, we observed that surviving cancer tissues and cells after radiotherapy had significantly greater glutathione to oxidized glutathione (GSH/GSSG) ratios and lower lipid reactive oxygen species (ROS) and malondialdehyde (MDA) levels than nonirradiated tumors and cells. Untargeted lipidomic analyses revealed that oleic acid (OA) and palmitoleic acid (POA) were the most significantly upregulated unsaturated fatty acids in irradiated surviving cancer cells compared with those in control cancer cells irradiated with IR. Both OA and POA could protect cancer cells from the killing effects of the ferroptosis inducer erastin and RSL3, and OA had a stronger protective effect than POA, resulting in lower lipid ROS production than POA. Mechanistically, OA protected cells from ferroptosis caused by the accumulation of polyunsaturated fatty acid-containing phospholipids in an ACSL3-dependent manner. A mouse model demonstrated that ACSL3 knockdown combined with imidazole ketone erastin synergistically enhanced antitumor effects in radiation-resistant tumors in vivo. Our study reveals previously undiscovered associations between radiation and fatty acid metabolism and ferroptosis, providing a novel treatment strategy for overcoming cancer radioresistance.
ArticleNumber	184
Author	Li, Jiuming Feng, Yuyang Cao, Yulin Zhou, Leyuan Chen, Ying Wang, Yuanben Yao, Surui Liu, Bingxin Huang, Liuying Liu, Zhiang Yin, Yuan Huang, Zhaohui
Author_xml	– sequence: 1 givenname: Yulin surname: Cao fullname: Cao, Yulin organization: Wuxi Cancer Institute, Affiliated Hospital of Jiangnan University, Laboratory of Cancer Epigenetics, Wuxi School of Medicine, Jiangnan University – sequence: 2 givenname: Jiuming surname: Li fullname: Li, Jiuming organization: Wuxi Cancer Institute, Affiliated Hospital of Jiangnan University, Laboratory of Cancer Epigenetics, Wuxi School of Medicine, Jiangnan University – sequence: 3 givenname: Ying surname: Chen fullname: Chen, Ying organization: Wuxi Cancer Institute, Affiliated Hospital of Jiangnan University, Laboratory of Cancer Epigenetics, Wuxi School of Medicine, Jiangnan University – sequence: 4 givenname: Yuanben surname: Wang fullname: Wang, Yuanben organization: Wuxi Cancer Institute, Affiliated Hospital of Jiangnan University, Laboratory of Cancer Epigenetics, Wuxi School of Medicine, Jiangnan University – sequence: 5 givenname: Zhiang surname: Liu fullname: Liu, Zhiang organization: Wuxi Cancer Institute, Affiliated Hospital of Jiangnan University, Laboratory of Cancer Epigenetics, Wuxi School of Medicine, Jiangnan University – sequence: 6 givenname: Liuying surname: Huang fullname: Huang, Liuying organization: Wuxi Cancer Institute, Affiliated Hospital of Jiangnan University, Laboratory of Cancer Epigenetics, Wuxi School of Medicine, Jiangnan University – sequence: 7 givenname: Bingxin surname: Liu fullname: Liu, Bingxin organization: Wuxi Cancer Institute, Affiliated Hospital of Jiangnan University, Laboratory of Cancer Epigenetics, Wuxi School of Medicine, Jiangnan University – sequence: 8 givenname: Yuyang surname: Feng fullname: Feng, Yuyang organization: Wuxi Cancer Institute, Affiliated Hospital of Jiangnan University – sequence: 9 givenname: Surui surname: Yao fullname: Yao, Surui organization: Wuxi Cancer Institute, Affiliated Hospital of Jiangnan University, Laboratory of Cancer Epigenetics, Wuxi School of Medicine, Jiangnan University – sequence: 10 givenname: Leyuan surname: Zhou fullname: Zhou, Leyuan organization: Laboratory of Cancer Epigenetics, Wuxi School of Medicine, Jiangnan University, Department of Radiation Oncology, Affiliated Hospital of Jiangnan University – sequence: 11 givenname: Yuan surname: Yin fullname: Yin, Yuan email: yinyuandiana@jiangnan.edu.cn organization: Wuxi Cancer Institute, Affiliated Hospital of Jiangnan University, Laboratory of Cancer Epigenetics, Wuxi School of Medicine, Jiangnan University – sequence: 12 givenname: Zhaohui orcidid: 0000-0002-0117-9976 surname: Huang fullname: Huang, Zhaohui email: zhaohuihuang@jiangnan.edu.cn organization: Wuxi Cancer Institute, Affiliated Hospital of Jiangnan University, Laboratory of Cancer Epigenetics, Wuxi School of Medicine, Jiangnan University
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/40102409$$D View this record in MEDLINE/PubMed
BookMark	eNp9Uk1v1DAQtVARbZf-AQ4oEhcuAX_lwydUrYBWWsQBOFsT28l6lbUX20Haf4-zKaXtoT7Y1sx7zzOed4nOnHcGoTcEfyCYtR8jJ5yIEtOqxE1F6hK_QBcUc1LythVnD-7n6CrGHc6LsQyvX6FzjgmmHIsL1H3zzk8uQpoCJKOLHlI6FqCsjsUh-L1PplDglAlFAG19MNHGNAeK7lhYt7WdTdYNRW9C8Ifkc7pI2-CnYVtcr39s2Gv0socxmqu7c4V-ffn8c31Tbr5_vV1fb0pVcZbKXnc1xzXFLdOa8h5Ad0Q0ShGh-qbudSUanjvoNMGNIFSrjAVR93VD6hobtkK3i672sJOHYPcQjtKDlaeAD4OEkKwajWyACN6pXgDhnEILFW0FKN5g2mmmWdb6tGgdpm5vtDIuBRgfiT7OOLuVg_8jCRHzx88K7-8Ugv89mZjk3kZlxhGc8VOUjDRty0iVtxV69wS681Nw-a9OqDzoGtOMevuwpPta_s0yA-gCUMHHGEx_DyFYzp6Ri2dkNoE8eUbiTGqfkJRNkKyf27Lj81S2UGN-xw0m_C_7GdZfVhvV-Q
CitedBy_id	crossref_primary_10_1016_j_tranon_2025_102401 crossref_primary_10_3389_fimmu_2025_1591172 crossref_primary_10_1016_j_critrevonc_2025_104878 crossref_primary_10_3390_biom15050670
Cites_doi	10.3390/cancers14235896 10.1016/j.redox.2022.102413 10.3389/fcell.2021.675617 10.1016/j.freeradbiomed.2024.08.026 10.1016/j.cbi.2020.109325 10.1073/pnas.2006828117 10.1038/s41467-022-29905-1 10.1186/s12944-017-0481-y 10.3390/ijms222212603 10.1016/j.tcb.2020.02.009 10.1158/2159-8290.CD-19-0338 10.1038/s41586-020-2623-z 10.1038/s41598-019-49486-2 10.1038/nchembio.2238 10.1016/j.redox.2023.102677 10.1038/s41419-023-05930-w 10.1016/j.cell.2017.09.021 10.1172/JCI127201 10.1023/B:CANC.0000031769.14728.bc 10.1007/s13238-021-00841-y 10.1155/2022/3403009 10.1016/j.chembiol.2018.11.016 10.1002/pmic.202100308 10.1021/acschembio.9b00939 10.1186/s12943-022-01530-y 10.1016/j.ejphar.2021.174397 10.1186/s12943-022-01675-w 10.1186/s13046-022-02567-z 10.1038/s41571-020-00462-0 10.1016/j.canlet.2023.216329 10.1038/s41419-023-05571-z 10.1016/j.freeradbiomed.2023.03.013 10.20892/j.issn.2095-3941.2020.0219 10.1038/nrclinonc.2016.60 10.1038/s41422-019-0263-3 10.1080/09553000110104065 10.1016/j.cell.2012.03.042 10.1038/s41419-022-05242-5 10.18388/abp.2000_3945 10.1016/j.cmet.2019.11.010 10.1371/journal.pbio.2006203 10.1016/j.chembiol.2019.05.002
ContentType	Journal Article
Copyright	The Author(s) 2025 corrected publication 2025 2025. The Author(s). Copyright Springer Nature B.V. Dec 2025 The Author(s) 2025 2025
Copyright_xml	– notice: The Author(s) 2025 corrected publication 2025 – notice: 2025. The Author(s). – notice: Copyright Springer Nature B.V. Dec 2025 – notice: The Author(s) 2025 2025
DBID	C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88A 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M2P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA
DOI	10.1038/s41419-025-07516-0
DatabaseName	Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection ProQuest Health & Medical Collection Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Central (New) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	CrossRef Publicly Available Content Database MEDLINE - Academic MEDLINE
Database_xml	– sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Biology
EISSN	2041-4889
EndPage	13
ExternalDocumentID	oai_doaj_org_article_7a194bcf9a1442a8a5289ac4702bd3d3 PMC11920413 40102409 10_1038_s41419_025_07516_0
Genre	Journal Article
GrantInformation_xml	– fundername: Natural Science Foundation of Jiangsu Province (Jiangsu Provincial Natural Science Foundation) grantid: No. BK20211033 funderid: https://doi.org/10.13039/501100004608 – fundername: Wuxi Taihu Lake Talent Plan for Leading Talents in Medical and Health Profession, Wuxi Medical Key Discipline (ZDXK2021002) – fundername: Postgraduate Research & Practice Innovation Program of Jiangsu Province (KYCX23_2521) – fundername: Top Talent Support Program for Young and Middle-aged People of Wuxi Health Committee (BJ2023060) – fundername: National Natural Science Foundation of China (National Science Foundation of China) grantid: 82473060; 82173063; 82472939; 82173193 funderid: https://doi.org/10.13039/501100001809 – fundername: National Natural Science Foundation of China (National Science Foundation of China) grantid: 82173063 – fundername: Natural Science Foundation of Jiangsu Province (Jiangsu Provincial Natural Science Foundation) grantid: No. BK20211033 – fundername: National Natural Science Foundation of China (National Science Foundation of China) grantid: 82473060 – fundername: National Natural Science Foundation of China (National Science Foundation of China) grantid: 82173193 – fundername: National Natural Science Foundation of China (National Science Foundation of China) grantid: 82472939
GroupedDBID	--- 0R~ 53G 5VS 70F 7X7 88I 8FE 8FH 8FI 8FJ AAJSJ AASML ABUWG ACGFS ADBBV AENEX AFKRA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO E3Z EBLON EBS EMOBN FRP FYUFA GNUQQ GROUPED_DOAJ HCIFZ HMCUK HYE HZ~ KQ8 LK8 M2P M7P M~E NAO O5R O5S O9- OK1 PHGZM PHGZT PIMPY PMFND PQQKQ PROAC RNT RPM SNYQT TR2 UKHRP W2D AAYXX AFFHD CITATION PQGLB CGR CUY CVF ECM EIF NPM 3V. 7XB 88A 8FK K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS Q9U 7X8 PUEGO 5PM
ID	FETCH-LOGICAL-c543t-fdb64062083dd24faadb197cc19cf76fd5974330bd107912dc620a96f671660e3
IEDL.DBID	DOA
ISICitedReferencesCount	8
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001449004400002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	2041-4889
IngestDate	Fri Oct 03 12:52:50 EDT 2025 Tue Nov 04 02:02:42 EST 2025 Fri Sep 05 08:20:42 EDT 2025 Tue Oct 07 06:42:58 EDT 2025 Mon Jul 21 06:03:02 EDT 2025 Sat Nov 29 07:51:32 EST 2025 Tue Nov 18 21:21:16 EST 2025 Wed Jun 04 01:15:20 EDT 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	1
Language	English
License	2025. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c543t-fdb64062083dd24faadb197cc19cf76fd5974330bd107912dc620a96f671660e3
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23
ORCID	0000-0002-0117-9976
OpenAccessLink	https://doaj.org/article/7a194bcf9a1442a8a5289ac4702bd3d3
PMID	40102409
PQID	3178414602
PQPubID	2041963
PageCount	13
ParticipantIDs	doaj_primary_oai_doaj_org_article_7a194bcf9a1442a8a5289ac4702bd3d3 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11920413 proquest_miscellaneous_3178831588 proquest_journals_3178414602 pubmed_primary_40102409 crossref_primary_10_1038_s41419_025_07516_0 crossref_citationtrail_10_1038_s41419_025_07516_0 springer_journals_10_1038_s41419_025_07516_0
PublicationCentury	2000
PublicationDate	2025-03-18
PublicationDateYYYYMMDD	2025-03-18
PublicationDate_xml	– month: 03 year: 2025 text: 2025-03-18 day: 18
PublicationDecade	2020
PublicationPlace	London
PublicationPlace_xml	– name: London – name: England
PublicationTitle	Cell death & disease
PublicationTitleAbbrev	Cell Death Dis
PublicationTitleAlternate	Cell Death Dis
PublicationYear	2025
Publisher	Nature Publishing Group UK Springer Nature B.V Nature Publishing Group
Publisher_xml	– name: Nature Publishing Group UK – name: Springer Nature B.V – name: Nature Publishing Group
References	H Feng (7516_CR17) 2018; 16 P Li (7516_CR37) 2022; 13 Z Yuan (7516_CR2) 2022; 2022 DR Spitz (7516_CR5) 2004; 23 X Lang (7516_CR11) 2019; 9 J Quan (7516_CR41) 2021; 909 G Shan (7516_CR14) 2024; 224 J Yi (7516_CR29) 2019; 26 7516_CR42 G Lei (7516_CR10) 2020; 30 BR Stockwell (7516_CR12) 2017; 171 X Xie (7516_CR26) 2023; 14 S Shaikh (7516_CR38) 2017; 16 HY Chuang (7516_CR39) 2019; 9 MT Snaebjornsson (7516_CR18) 2020; 31 OI Shadyro (7516_CR6) 2002; 78 J Chen (7516_CR40) 2020; 17 LF Ye (7516_CR1) 2020; 15 Z Li (7516_CR36) 2023; 201 Y Luo (7516_CR28) 2021; 333 Y Cao (7516_CR20) 2019; 129 X Chen (7516_CR3) 2021; 18 ZH Yuan (7516_CR21) 2021; 9 SJ Dixon (7516_CR7) 2012; 149 JM Ubellacker (7516_CR27) 2020; 585 7516_CR8 H Zhou (7516_CR30) 2022; 55 BR Stockwell (7516_CR34) 2020; 30 L Magtanong (7516_CR24) 2019; 26 UE Martinez-Outschoorn (7516_CR19) 2017; 14 J Rodencal (7516_CR33) 2023; 23 Z Chen (7516_CR13) 2023; 14 G Lei (7516_CR9) 2021; 12 P Koppula (7516_CR15) 2022; 13 VE Kagan (7516_CR23) 2017; 13 JM Gebicki (7516_CR4) 2000; 47 X Wang (7516_CR25) 2022; 21 M De Martino (7516_CR22) 2023; 570 S Liu (7516_CR31) 2023; 62 Y Li (7516_CR35) 2023; 42 JY Lee (7516_CR32) 2020; 117 C Zhang (7516_CR16) 2022; 21 40461470 - Cell Death Dis. 2025 Jun 3;16(1):430. doi: 10.1038/s41419-025-07726-6.
References_xml	– ident: 7516_CR42 doi: 10.3390/cancers14235896 – volume: 55 year: 2022 ident: 7516_CR30 publication-title: Redox Biol doi: 10.1016/j.redox.2022.102413 – volume: 9 year: 2021 ident: 7516_CR21 publication-title: Front Cell Dev Biol doi: 10.3389/fcell.2021.675617 – volume: 224 start-page: 310 year: 2024 ident: 7516_CR14 publication-title: Free Radic Biol Med doi: 10.1016/j.freeradbiomed.2024.08.026 – volume: 333 year: 2021 ident: 7516_CR28 publication-title: Chem Biol Interact doi: 10.1016/j.cbi.2020.109325 – volume: 117 start-page: 32433 year: 2020 ident: 7516_CR32 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.2006828117 – volume: 13 year: 2022 ident: 7516_CR15 publication-title: Nat Commun doi: 10.1038/s41467-022-29905-1 – volume: 16 start-page: 92 year: 2017 ident: 7516_CR38 publication-title: Lipids Health Dis doi: 10.1186/s12944-017-0481-y – ident: 7516_CR8 doi: 10.3390/ijms222212603 – volume: 30 start-page: 478 year: 2020 ident: 7516_CR34 publication-title: Trends Cell Biol doi: 10.1016/j.tcb.2020.02.009 – volume: 9 start-page: 1673 year: 2019 ident: 7516_CR11 publication-title: Cancer Discov doi: 10.1158/2159-8290.CD-19-0338 – volume: 585 start-page: 113 year: 2020 ident: 7516_CR27 publication-title: Nature doi: 10.1038/s41586-020-2623-z – volume: 9 year: 2019 ident: 7516_CR39 publication-title: Sci Rep doi: 10.1038/s41598-019-49486-2 – volume: 13 start-page: 81 year: 2017 ident: 7516_CR23 publication-title: Nat Chem Biol doi: 10.1038/nchembio.2238 – volume: 62 year: 2023 ident: 7516_CR31 publication-title: Redox Biol doi: 10.1016/j.redox.2023.102677 – volume: 14 year: 2023 ident: 7516_CR13 publication-title: Cell Death Dis doi: 10.1038/s41419-023-05930-w – volume: 171 start-page: 273 year: 2017 ident: 7516_CR12 publication-title: Cell doi: 10.1016/j.cell.2017.09.021 – volume: 129 start-page: 3006 year: 2019 ident: 7516_CR20 publication-title: J Clin Invest doi: 10.1172/JCI127201 – volume: 23 start-page: 311 year: 2004 ident: 7516_CR5 publication-title: Cancer Metastasis Rev doi: 10.1023/B:CANC.0000031769.14728.bc – volume: 12 start-page: 836 year: 2021 ident: 7516_CR9 publication-title: Protein Cell doi: 10.1007/s13238-021-00841-y – volume: 2022 year: 2022 ident: 7516_CR2 publication-title: Oxid Med Cell Longev doi: 10.1155/2022/3403009 – volume: 26 start-page: 420 year: 2019 ident: 7516_CR24 publication-title: Cell Chem Biol doi: 10.1016/j.chembiol.2018.11.016 – volume: 23 year: 2023 ident: 7516_CR33 publication-title: Proteomics doi: 10.1002/pmic.202100308 – volume: 15 start-page: 469 year: 2020 ident: 7516_CR1 publication-title: ACS Chem Biol doi: 10.1021/acschembio.9b00939 – volume: 21 year: 2022 ident: 7516_CR16 publication-title: Mol Cancer doi: 10.1186/s12943-022-01530-y – volume: 909 year: 2021 ident: 7516_CR41 publication-title: Eur J Pharm doi: 10.1016/j.ejphar.2021.174397 – volume: 21 year: 2022 ident: 7516_CR25 publication-title: Mol Cancer doi: 10.1186/s12943-022-01675-w – volume: 42 start-page: 6 year: 2023 ident: 7516_CR35 publication-title: J Exp Clin Cancer Res doi: 10.1186/s13046-022-02567-z – volume: 18 start-page: 280 year: 2021 ident: 7516_CR3 publication-title: Nat Rev Clin Oncol doi: 10.1038/s41571-020-00462-0 – volume: 570 year: 2023 ident: 7516_CR22 publication-title: Cancer Lett doi: 10.1016/j.canlet.2023.216329 – volume: 14 year: 2023 ident: 7516_CR26 publication-title: Cell Death Dis doi: 10.1038/s41419-023-05571-z – volume: 201 start-page: 41 year: 2023 ident: 7516_CR36 publication-title: Free Radic Biol Med doi: 10.1016/j.freeradbiomed.2023.03.013 – volume: 17 start-page: 740 year: 2020 ident: 7516_CR40 publication-title: Cancer Biol Med doi: 10.20892/j.issn.2095-3941.2020.0219 – volume: 14 start-page: 11 year: 2017 ident: 7516_CR19 publication-title: Nat Rev Clin Oncol doi: 10.1038/nrclinonc.2016.60 – volume: 30 start-page: 146 year: 2020 ident: 7516_CR10 publication-title: Cell Res doi: 10.1038/s41422-019-0263-3 – volume: 78 start-page: 211 year: 2002 ident: 7516_CR6 publication-title: Int J Radiat Biol doi: 10.1080/09553000110104065 – volume: 149 start-page: 1060 year: 2012 ident: 7516_CR7 publication-title: Cell doi: 10.1016/j.cell.2012.03.042 – volume: 13 year: 2022 ident: 7516_CR37 publication-title: Cell Death Dis doi: 10.1038/s41419-022-05242-5 – volume: 47 start-page: 901 year: 2000 ident: 7516_CR4 publication-title: Acta Biochim Pol doi: 10.18388/abp.2000_3945 – volume: 31 start-page: 62 year: 2020 ident: 7516_CR18 publication-title: Cell Metab doi: 10.1016/j.cmet.2019.11.010 – volume: 16 start-page: e2006203 year: 2018 ident: 7516_CR17 publication-title: PLoS Biol doi: 10.1371/journal.pbio.2006203 – volume: 26 start-page: 621 year: 2019 ident: 7516_CR29 publication-title: Cell Chem Biol doi: 10.1016/j.chembiol.2019.05.002 – reference: 40461470 - Cell Death Dis. 2025 Jun 3;16(1):430. doi: 10.1038/s41419-025-07726-6.
SSID	ssj0000330256
Score	2.4503822
Snippet	Radioresistance is a major challenge in tumor radiotherapy and involves in a mixture of cellular events, including ferroptosis, a new type of programmed cell... Abstract Radioresistance is a major challenge in tumor radiotherapy and involves in a mixture of cellular events, including ferroptosis, a new type of...
SourceID	doaj pubmedcentral proquest pubmed crossref springer
SourceType	Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	184
SubjectTerms	13/51 14/28 631/67/395 64/60 692/699/67/1059/2326 692/699/67/1059/485 692/699/67/1504/1885/1777 82/58 82/80 82/81 Animals Antibodies Antitumor activity Apoptosis Biochemistry Biomedical and Life Sciences Cancer Cell Biology Cell Culture Cell death Cell Line, Tumor Coenzyme A Ligases - genetics Coenzyme A Ligases - metabolism Fatty acids Fatty Acids, Monounsaturated - metabolism Fatty Acids, Monounsaturated - pharmacology Female Ferroptosis Ferroptosis - drug effects Ferroptosis - radiation effects Glutathione Humans Imidazole Immunology Life Sciences Lipids Long-Chain-Fatty-Acid-CoA Ligase Mice Mice, Nude Neoplasms - metabolism Neoplasms - pathology Neoplasms - radiotherapy Oleic acid Oleic Acid - pharmacology Palmitoleic acid Phospholipids Piperazines - pharmacology Polyunsaturated fatty acids Radiation therapy Radiation Tolerance - drug effects Radioresistance Reactive oxygen species Reactive Oxygen Species - metabolism Tumors
SummonAdditionalLinks	– databaseName: Biological Science Database dbid: M7P link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Jb9UwELaggNQLOyVQkJG4gVUnThznhEpFxaGqKrGoN8srjYSSR5IivX_P2PFL9Vh64Ro7kZ1vxjOfPZ5B6LUzVClBKyK8qknJmSZKmYJoV1GvrKY61gb8elKfnorz8-YsbbiNKaxysybGhdr2JuyRH4CdEyWoNS3erX6QUDUqnK6mEho30a2QJYHF0L2zZY-FAlkHk57uylAmDkb4RLi1U1QEbGUOZHrLHsW0_X_zNf8Mmfzt3DSao-N7_zuR--huckTx4Sw5D9AN1z1Ed-bSlOtHSIOyh-vqIe8nuKMWezVNa6xMa0e8ijF8DpsgMgMelG17oO3BFYUHWK9x2120ug0h1di7YehXUw_NOFUFwodHn07YY_Tl-MPno48k1WMgpirZRLzVHOx_AV6btUXpFWCZN7UxeWN8zb0N5AR-ubbAKZu8sAb6qoZ7DqSMU8eeoJ2u79xThHlpasEd5VS5stG1sEobYx0gZrzmKkP5BhVpUrLyUDPju4yH5kzIGUkJSMqIpKQZerO8s5pTdVzb-30Ae-kZ0mzHB_3wTSatlbXKm1Ib3yjgnYUSqgJ-qkxZ00JbZlmG9jcYy6T7o7wCOEOvlmbQ2nAUozrXX859BMsrITK0N0vWMpIypPkD2p0hsSVzW0Pdbunai5gZPAd_nYJbkqG3G_G8Gte__8Wz66fxHO0WUWMYycU-2pmGS_cC3TY_p3YcXkaV-wUTGTS9 priority: 102 providerName: ProQuest
Title	Monounsaturated fatty acids promote cancer radioresistance by inhibiting ferroptosis through ACSL3
URI	https://link.springer.com/article/10.1038/s41419-025-07516-0 https://www.ncbi.nlm.nih.gov/pubmed/40102409 https://www.proquest.com/docview/3178414602 https://www.proquest.com/docview/3178831588 https://pubmed.ncbi.nlm.nih.gov/PMC11920413 https://doaj.org/article/7a194bcf9a1442a8a5289ac4702bd3d3
Volume	16
WOSCitedRecordID	wos001449004400002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2041-4889 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000330256 issn: 2041-4889 databaseCode: DOA dateStart: 20100101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2041-4889 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000330256 issn: 2041-4889 databaseCode: M~E dateStart: 20100101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 2041-4889 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000330256 issn: 2041-4889 databaseCode: M7P dateStart: 20100101 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2041-4889 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000330256 issn: 2041-4889 databaseCode: 7X7 dateStart: 20100101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2041-4889 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000330256 issn: 2041-4889 databaseCode: BENPR dateStart: 20100101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 2041-4889 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000330256 issn: 2041-4889 databaseCode: PIMPY dateStart: 20100101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVPQU databaseName: Science Database customDbUrl: eissn: 2041-4889 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000330256 issn: 2041-4889 databaseCode: M2P dateStart: 20100101 isFulltext: true titleUrlDefault: https://search.proquest.com/sciencejournals providerName: ProQuest
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEB7apIVeSt91my4q9NaayC9JPiYhoYVkMX2xPRk9iaHYi9cp7L_vSPZus31eetHBkrGYh-f70GgG4JXVVEpBi1g4yeOcZSqWUqexsgV10iiqQm_Az-d8PheLRVlda_Xlc8LG8sCj4A65RJqttCslQv9UClkgRZA65zRVJjOhzieinmtkKvyDkaZjMJ9uydBMHK7yJPf3ddIixiiZII3eiUShYP_vUOavyZI_nZiGQHR2D-5OCJIcjTu_Dzds-wBujz0l1w9BoZf6e-a-YCfiSEOcHIY1kboxK7IMyXeWaK_rnvTSNB3ybY8h8QFRa9K0l41qfC40cbbvu-XQ4TSZ2vmQo5MP59kj-HR2-vHkbTw1Uoh1kWdD7IxiGLhRTpkxae4kKiEpudZJqR1nznhWgRJTBslgmaRG41pZMseQTTFqs8ew13atfQqE5ZoLZimj0ual4sJIpbWxKHDtFJMRJBuh1nqqMu6bXXytw2l3JupRETUqog6KqGkEr7fvLMcaG39dfex1tV3p62OHB2g19WQ19b-sJoKDjabryWlXNUIpgZ9jNI3g5XYa3c2focjWdlfjGpElhRARPBkNY7uT3NfnQ74cgdgxmZ2t7s60zWUo6Z0g0KaIJyJ4s7GuH_v6syye_Q9ZPIc7aXCLLE7EAewN_ZV9Abf0t6FZ9TO4yRc8jGIG-8en8-r9LPgajhdp5UeO43717qL68h1mCC28
linkProvider	Directory of Open Access Journals
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jb9QwFH4qU1C5sC-BAkaCE0R1dueAUClUHXU6GomC2lPw2kZCyZCkoPlT_Eaes0w1LL31wNVL9Ox8b7Of3wN4oSXlnNHIZYYnbhgHwuVc-q7QETVcCSra2oCfJ8l0yo6O0tka_BzewtiwykEmtoJaldKekW-hnmMhsjX1386_ubZqlL1dHUpodLDY14sf6LLVb8bv8f--9P3dD4c7e25fVcCVURg0rlEiRi3mo-2hlB8ajhR5aSKll0qTxEZZExu9fKHQM0o9X0kcy9PYxOhaxFQH-N0rsB4i2NkI1mfjg9nx8lSH4kQ0IvrXOTRgWzUSbd8J-ZGL2tlD931FA7aFAv5m3f4ZpPnbTW2rAHdv_m9bdwtu9KY22e544zas6eIOXOuKby7ugkBxZh_k28ymaHArYnjTLAiXuarJvI1S1ERapqhIxVVeVrq2xjY2ELEgeXGai9wGjROjq6qcNyV2k77uEdne-TgJ7sGnS1ngfRgVZaEfAolDmbBY05hyHaYiYYoLKZVGhEgjYu6AN6Agk306dlsV5GvWhgUELOuQkyFyshY5GXXg1XLOvEtGcuHodxZcy5E2kXjbUFYnWS-XsoR7aSikSTl61j5nPEIPnMswob5QgQoc2BwwlfXSrc7OAeXA82U3yiV72cQLXZ51Y1jgRYw58KBD8pKS0CYyDGnqAFvB-Aqpqz1FftrmPvfQI6FoeDnwemCHc7r-vRePLl7GM9jYOzyYZJPxdP8xXPdbbg1cj23CqKnO9BO4Kr83eV097RmewJfLZpRfo-6SRQ
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jb9QwFH4qZREX9iVQwEhwgmic3TkgVFpGVB2NRmJRb8ErjYSSIUlB89f4dTw7yVTD0lsPXL1Ez873Nvv5PYBnWlLOGU18Znjmx2kkfM5l6AudUMOVoMLVBvw0y-ZzdnSUL7bg5_gWxoZVjjLRCWpVS3tGPkE9x2JkaxpOzBAWsdifvl5-820FKXvTOpbT6CFyqFc_0H1rXx3s479-HobTtx_23vlDhQFfJnHU-UaJFDVaiHaIUmFsOFIX5JmUQS5NlhplzW30-IVCLykPQiVxLM9Tk6KbkVId4XcvwMXMJi13YYOL9fkOxWloTgzvdGjEJi2Sb18MhYmPejpAR35DF7qSAX-zc_8M1_ztztapwun1_3kTb8C1wQAnuz3H3IQtXd2Cy31JztVtECjk7DN9m-8UzXBFDO-6FeGyVC1ZuthFTaRllYY0XJV1o1trgmMDEStSVselKG0oOTG6aeplV2M3Gaohkd2997PoDnw8lwXehe2qrvR9IGksM5ZqmlKu41xkTHEhpdKIFmlEyj0IRkQUckjSbmuFfC1csEDEih5FBaKocCgqqAcv1nOWfYqSM0e_sUBbj7TpxV1D3XwpBmlVZDzIYyFNztHfDjnjCfrlXMYZDYWKVOTBzoivYpB5bXEKLg-errtRWtkrKF7p-qQfw6IgYcyDez2q15TENr1hTHMP2AbeN0jd7KnKY5cRPUA_haI55sHLkTVO6fr3Xjw4exlP4ApyRzE7mB8-hKuhY9zID9gObHfNiX4El-T3rmybx47zCXw-by75BQnqmYQ
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Monounsaturated+fatty+acids+promote+cancer+radioresistance+by+inhibiting+ferroptosis+through+ACSL3&rft.jtitle=Cell+death+%26+disease&rft.au=Cao%2C+Yulin&rft.au=Li%2C+Jiuming&rft.au=Chen%2C+Ying&rft.au=Wang%2C+Yuanben&rft.date=2025-03-18&rft.eissn=2041-4889&rft.volume=16&rft.issue=1&rft.spage=184&rft_id=info:doi/10.1038%2Fs41419-025-07516-0&rft_id=info%3Apmid%2F40102409&rft.externalDocID=40102409
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-4889&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-4889&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-4889&client=summon